Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT03875079
Brief Title: A Study To Evaluate Safety And Therapeutic Activity Of RO6874281 In Combination With Pembrolizumab, In Participants With Advanced Or Metastatic Melanoma

First Submitted : March 13, 2019
First Submitted that Met QC Criteria : March 13, 2019
First Posted : March 14, 2019

Last Update Submitted that Met QC Criteria : December 20, 2021
Last Update Posted : December 21, 2021